Clinical Trial Update: Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on co-administration of GnRH agonist and hCG for final oocyte maturation in infertility patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)
• hCG (human chorionic gonadotropin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Infertility | Phase 4 | Status: COMPLETED